Call Us + 33 1 84 88 31 00

Article L5134-3 of the French Public Health Code

The following are determined by decree in the Conseil d’Etat: 1° Measures for the application of Article L. 5134-1; 2° The specific conditions for issuing contraceptives in Guadeloupe, French Guiana, Martinique, La Réunion, Mayotte and Saint-Barthélemy and Saint-Martin.

Read More »

Article L5135-1 of the French Public Health Code

Manufacturers and dealers in gynaecological equipment are prohibited from selling medical devices for the voluntary termination of pregnancy to persons who are not members of the medical profession or who do not themselves sell surgical equipment.

Read More »

Article L5137-1 of the French Public Health Code

Foodstuffs intended for special medical purposes as defined in Article 2(2)(g) of Regulation (EU) No 609/2013 of the European Parliament and of the Council of 12 June 2013 on foodstuffs intended for infants and young children, foods for special medical purposes and total daily ration replacements for weight control and repealing Council Directive 92/52/EEC, Commission Directives 96/8/EC, 1999/21/EC, 2006/125/EC and 2006/141/EC, Directive 2009/39/EC of the European Parliament and of the…

Read More »

Article L5137-3 of the French Public Health Code

When the consumption of a foodstuff intended for special medical purposes may present serious health risks if misused, the producer and distributor shall notify the competent administrative authority designated by order of the ministers responsible for consumption and health. When it is established that the consumption of a foodstuff intended for special medical purposes presents serious health risks in the event of misuse, the Minister for Health shall make it…

Read More »

Article L5138-1 of the French Public Health Code

The activities of manufacturing, importing and distributing active substances, including with a view to export, may only be carried out in establishments authorised by the National Agency for the Safety of Medicines and Health Products, whether these substances are used in the manufacture of medicinal products for human use or in the manufacture of veterinary medicinal products in accordance with Articles 93 and 95 of Regulation (EU) 2019/6 of 11…

Read More »

Article L5138-2 of the French Public Health Code

I.-“Raw materials for pharmaceutical use” means all the constituents of medicinal products within the meaning of Article L. 5111-1, i.e. : 1° The active substance or substances. An active substance is any substance or mixture of substances intended to be used for the manufacture of a medicinal product and which, when used for its production, becomes an active component of this medicinal product exerting a pharmacological, immunological or metabolic action…

Read More »

Article L5138-3 of the French Public Health Code

Raw materials for pharmaceutical use comply with pharmacopoeia specifications where these exist. Active substances used as starting materials in medicinal products for human use are manufactured and distributed in accordance with good manufacturing practice, the principles of which are defined by the Director General of the Agence nationale de sécurité du médicament et des produits de santé. Active substances used as starting materials in veterinary medicinal products shall be manufactured…

Read More »

Article L5138-3-1 of the French Public Health Code

For the manufacture of medicinal products for veterinary use, the pharmaceutical establishments mentioned in article L. 5142-1, veterinarians, dispensing pharmacies and persons authorised to prepare self-vaccines for veterinary use as well as persons authorised to prepare veterinary medicinal products mentioned in article L. 5142-1-2 use, as starting materials for pharmaceutical use, active substances which meet the requirements of the second paragraph of article L. 5138-3.

Read More »

Article L5138-4 of the French Public Health Code

When, as part of its inspection powers, the Agence nationale de sécurité du médicament et des produits de santé finds that the manufacture or repackaging and relabelling for distribution of raw materials for pharmaceutical use complies with the good practices provided for in Article L. 5138-3, it issues a certificate of compliance, except for the distribution of excipients. Any establishment carrying out one of the activities mentioned in the first…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.